Your browser doesn't support javascript.
loading
Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711.
Lindström, Erik; Rizoska, Biljana; Henderson, Ian; Terelius, Ylva; Jerling, Markus; Edenius, Charlotte; Grabowska, Urszula.
Affiliation
  • Lindström E; Medivir AB, Box 1086, 141 22, Huddinge, Sweden.
  • Rizoska B; Medivir AB, Box 1086, 141 22, Huddinge, Sweden. miv711@medivir.com.
  • Henderson I; Medivir AB, Box 1086, 141 22, Huddinge, Sweden.
  • Terelius Y; Medivir AB, Box 1086, 141 22, Huddinge, Sweden.
  • Jerling M; Medivir AB, Box 1086, 141 22, Huddinge, Sweden.
  • Edenius C; Medivir AB, Box 1086, 141 22, Huddinge, Sweden.
  • Grabowska U; Medivir AB, Box 1086, 141 22, Huddinge, Sweden.
J Transl Med ; 16(1): 125, 2018 05 09.
Article in En | MEDLINE | ID: mdl-29743078
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organic Chemicals / Cysteine Proteinase Inhibitors / Cathepsin K Type of study: Clinical_trials Limits: Adult / Animals / Female / Humans / Male / Middle aged Language: En Journal: J Transl Med Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organic Chemicals / Cysteine Proteinase Inhibitors / Cathepsin K Type of study: Clinical_trials Limits: Adult / Animals / Female / Humans / Male / Middle aged Language: En Journal: J Transl Med Year: 2018 Document type: Article Affiliation country: Country of publication: